Article
The AI Tools Speeding Up Drug Discovery Come With Risky Fine Print
Researchers routinely use AI tools like AlphaFold and Schrödinger's software without scrutinizing license agreements that contain restrictions on commercial use, confidentiality, and mandatory disclosure requirements. These overlooked terms can create significant legal obstacles when translating academic innovations into commercial products, affecting everything from sponsored research agreements to patent filings and university spinouts.
Foley Hoag LLP